메뉴 건너뛰기




Volumn 60, Issue 8, 2003, Pages 1395-1396

Severe intoxication after phenytoin infusion: A preventable pharmacogenetic adverse reaction

Author keywords

[No Author keywords available]

Indexed keywords

CHARCOAL; DIAZEPAM; DOPAMINE; NORADRENALIN; PHENYTOIN; TOPIRAMATE;

EID: 0037461286     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.WNL.0000058756.61277.17     Document Type: Article
Times cited : (18)

References (7)
  • 1
    • 0034978572 scopus 로고    scopus 로고
    • The effect of genetic polymorphism of cytochrome P450 CYP2C9 on phenytoin dose requirement
    • van der Weide J, Steijns LSW, van Weelden MJM, et al. The effect of genetic polymorphism of cytochrome P450 CYP2C9 on phenytoin dose requirement. Pharmacogenetics 2001;11:287-291.
    • (2001) Pharmacogenetics , vol.11 , pp. 287-291
    • Van der Weide, J.1    Steijns, L.S.W.2    Van Weelden, M.J.M.3
  • 2
    • 0036263813 scopus 로고    scopus 로고
    • Cytochrome P450 2C9 polymorphisms: A comprehensive review of the in-vitro and human data
    • Lee RG, Goldstein JA, Pieper JA. Cytochrome P450 2C9 polymorphisms: a comprehensive review of the in-vitro and human data. Pharmacogenetics 2002;12:251-263.
    • (2002) Pharmacogenetics , vol.12 , pp. 251-263
    • Lee, R.G.1    Goldstein, J.A.2    Pieper, J.A.3
  • 3
    • 0037012465 scopus 로고    scopus 로고
    • Association between CYP2C9 genetic variants and anticoagulation-related outcomes during warfarin therapy
    • Higashi MK, Veenstra DL, Midori Komdo L, et al. Association between CYP2C9 genetic variants and anticoagulation-related outcomes during warfarin therapy. JAMA 2002;287:1690-1698.
    • (2002) JAMA , vol.287 , pp. 1690-1698
    • Higashi, M.K.1    Veenstra, D.L.2    Midori Komdo, L.3
  • 4
    • 0034042132 scopus 로고    scopus 로고
    • Genetic polymorphism of the CYP2C subfamily and excessive serum phenytoin with central nervous system intoxication
    • Ninomya H, Mamiya K, Matsuo S, Ieiri I, Higuci,S, Tashiro N. Genetic polymorphism of the CYP2C subfamily and excessive serum phenytoin with central nervous system intoxication. Ther Drug Monit 2000;22:230-232.
    • (2000) Ther Drug Monit , vol.22 , pp. 230-232
    • Ninomya, H.1    Mamiya, K.2    Matsuo, S.3    Ieiri, I.4    Higuci, S.5    Tashiro, N.6
  • 5
    • 0030858160 scopus 로고    scopus 로고
    • Genetic polymorphism of the CYP2C subfamily and its effect on the pharmacokinetics of phenytoin in Japanese patients with epilepsy
    • Odani A, Hashimoto Y, Otsuki Y, et al. Genetic polymorphism of the CYP2C subfamily and its effect on the pharmacokinetics of phenytoin in Japanese patients with epilepsy. Clin Pharmacol Ther 1997;62:287-292.
    • (1997) Clin Pharmacol Ther , vol.62 , pp. 287-292
    • Odani, A.1    Hashimoto, Y.2    Otsuki, Y.3
  • 7
    • 0028861660 scopus 로고
    • Detection of CYP2C9 polymorphism based on the polymerase chain reaction in Chinese
    • Wang SL, Huang J, Lai MD, Tsai JJ. Detection of CYP2C9 polymorphism based on the polymerase chain reaction in Chinese. Pharmacogenetics 1995;5:37-42.
    • (1995) Pharmacogenetics , vol.5 , pp. 37-42
    • Wang, S.L.1    Huang, J.2    Lai, M.D.3    Tsai, J.J.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.